Calumet, Inc. (NASDAQ:CLMT) SVP Gregory J. Morical Sells 25,123 Shares of Stock

Calumet, Inc. (NASDAQ:CLMT) SVP Gregory J. Morical sold 25,123 shares of the business’s stock in a transaction that occurred on Monday, June 16th. The stock was sold at an average price of $16.69, for a total transaction of $419,302.87. Following the completion of the sale, the senior vice president now owns 39,415 shares in the company, valued at $657,836.35. The trade was a 38.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Calumet Stock Performance

Shares of NASDAQ:CLMT opened at $16.88 on Wednesday. The firm has a 50 day simple moving average of $12.38 and a 200 day simple moving average of $15.24. Calumet, Inc. has a 52 week low of $7.68 and a 52 week high of $25.29. The company has a market cap of $1.46 billion, a PE ratio of -4.22 and a beta of 0.91.

Calumet (NASDAQ:CLMT) last announced its earnings results on Friday, May 9th. The oil and gas company reported ($1.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.41) by ($0.62). The business had revenue of $993.90 million for the quarter, compared to the consensus estimate of $899.62 million. The firm’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.51) earnings per share. On average, equities analysts predict that Calumet, Inc. will post -3.02 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on CLMT. HC Wainwright restated a “buy” rating and set a $33.00 target price on shares of Calumet in a report on Monday, March 3rd. Bank of America initiated coverage on Calumet in a research report on Tuesday, May 13th. They set a “buy” rating and a $15.00 price objective for the company. Wells Fargo & Company decreased their target price on Calumet from $23.00 to $21.00 and set an “overweight” rating on the stock in a report on Wednesday, May 14th. The Goldman Sachs Group cut their target price on Calumet from $16.00 to $14.00 and set a “buy” rating on the stock in a research report on Wednesday, April 30th. Finally, UBS Group raised Calumet from a “sell” rating to a “neutral” rating and reduced their target price for the company from $15.00 to $12.00 in a report on Monday, March 17th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $18.50.

Calumet Company Profile

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.